https://openbell.ai/ 2026-09-30T19:08:35.845Z hourly 1.0 https://openbell.ai/support 2026-09-30T19:08:35.845Z monthly 0.7 https://openbell.ai/privacy 2026-09-30T19:08:35.845Z monthly 0.5 https://openbell.ai/terms 2026-09-30T19:08:35.845Z monthly 0.5 https://openbell.ai/feed.json 2026-09-30T19:08:35.845Z hourly 0.8 https://openbell.ai/news/TORO:1790794815817 2026-09-30T19:00:15.817Z daily 0.9 https://cdn.brandfetch.io/TORO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of clean tanker companies are trading higher as investors weigh potential for alternatives to President Trump's proposed diesel export ban that still allow global trading of the fuel. openbell Financial News https://openbell.ai/news/CHCO:1790794776130 2026-09-30T18:59:36.130Z daily 0.9 https://cdn.brandfetch.io/CHCO/w/400/h/400?c=1idopYfmtR7ZKg8QMud City Holding Raises Quarterly Dividend From $0.87 To $1 Per Share City Holding Company (NASDAQ: CHCO), a bank holding company with a market capitalization of $6.8 billion, has announced a quarterly dividend increase from $0.87 to $1.00 per share. The new dividend will be applicable for shareholders of record as of October 15, 2026, and is set to be paid on October 30, 2026. This marks a 15% increase over the previous quarter's dividend. https://openbell.ai/news/TE:1790794253733 2026-09-30T18:50:53.733Z daily 0.9 https://cdn.brandfetch.io/TE/w/400/h/400?c=1idopYfmtR7ZKg8QMud T1 Energy Finds Another $50 Million for Its Big Texas Solar Ambitions T1 Energy Inc. (NYSE: TE) has raised an additional $50 million through a private placement of convertible senior notes to fund its G2_Austin solar cell manufacturing facility in Texas. This financing will support construction and infrastructure development for Phase 1 of the project, bringing the total outstanding principal of convertible notes to $170 million. T1 Energy's stock was up 0.53% to $3.79 in premarket trading, with analysts maintaining a Buy consensus rating and an average price forecast of $9.20. https://openbell.ai/news/RDW:1790794253511 2026-09-30T18:50:53.511Z daily 0.9 https://cdn.brandfetch.io/RDW/w/400/h/400?c=1idopYfmtR7ZKg8QMud Redwire Joins Race to Build Scalable AI Data Centers in Orbit Redwire Corp. (NYSE: RDW) has signed a memorandum of understanding with Sophia Space to develop scalable computing infrastructure in orbit, combining their technologies for orbital data centers. The partnership aims to explore demonstration missions and long-term designs for high-performance computing in space, targeting both government and commercial opportunities. Following the announcement, Redwire's stock rose nearly 3%, trading at $11.02, while analysts maintain a Hold consensus rating with an average price forecast of $15.13. https://openbell.ai/news/TE:1790794243981 2026-09-30T18:50:43.981Z daily 0.9 https://cdn.brandfetch.io/TE/w/400/h/400?c=1idopYfmtR7ZKg8QMud T1 Energy Finds Another $50 Million for Its Big Texas Solar Ambitions T1 Energy Inc. (NYSE: TE) has raised an additional $50 million through a private placement of convertible senior notes to fund its G2_Austin solar cell manufacturing facility in Texas. This financing, which is expected to close on September 30, will increase the total outstanding convertible notes to $170 million, with a maturity date of August 1, 2031. The funds will be used for construction, infrastructure development, and production-line equipment for Phase 1 of the project, as well as general corporate purposes. T1 Energy's stock was trading up 0.53% at $3.79 in premarket trading. https://openbell.ai/news/RDW:1790794241479 2026-09-30T18:50:41.479Z daily 0.9 https://cdn.brandfetch.io/RDW/w/400/h/400?c=1idopYfmtR7ZKg8QMud Redwire Joins Race to Build Scalable AI Data Centers in Orbit Redwire Corp. (NYSE: RDW) has signed a memorandum of understanding with Sophia Space to develop scalable computing infrastructure in orbit, combining their respective technologies for modular orbital computing and space infrastructure. The partnership aims to explore demonstration missions and long-term designs for orbital data centers, targeting both government and commercial opportunities, including potential contracts with U.S. defense agencies. Following the announcement, Redwire's stock rose nearly 3%, trading at $11.02, with analysts maintaining a Hold rating and an average price forecast of $15.13. https://openbell.ai/news/TE:1790794233202 2026-09-30T18:50:33.202Z daily 0.9 https://cdn.brandfetch.io/TE/w/400/h/400?c=1idopYfmtR7ZKg8QMud T1 Energy Finds Another $50 Million for Its Big Texas Solar Ambitions T1 Energy Inc. (NYSE: TE) has raised an additional $50 million through a private placement of convertible senior notes to fund its G2_Austin solar cell manufacturing facility in Texas. This financing will support construction and infrastructure development for Phase 1 of the project, with gross proceeds expected to be approximately $50.4 million before fees. Following this issuance, T1 Energy's total outstanding convertible notes will rise to $170 million, maturing on August 1, 2031. The company's stock was up 0.53% to $3.79 in premarket trading. https://openbell.ai/news/BMY:1790794092383 2026-09-30T18:48:12.383Z daily 0.9 https://cdn.brandfetch.io/BMY/w/400/h/400?c=1idopYfmtR7ZKg8QMud FDA Approves Bristol Myers Squibb's Camzyos As First Treatment For Children With Obstructive Hypertrophic Cardiomyopathy Weighing At Least 30 kg The FDA has approved Bristol Myers Squibb's drug Camzyos as the first treatment for children weighing at least 30 kg with obstructive hypertrophic cardiomyopathy. This approval marks a significant advancement in addressing the functional capacity and symptoms of this rare inherited heart condition. The approval could potentially impact the company's revenue and market position in the pediatric cardiology sector. https://openbell.ai/news/SRFM:1790794030088 2026-09-30T18:47:10.088Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Surf-Air-Mobility.jpg?width=250&height=187 Surf Air Mobility Adds Air Fuga To OperatorOS Roster, Names Jason Secore CFO Surf Air Mobility (NYSE: SRFM) has signed a definitive agreement with Air Fuga, making it the third customer for its OperatorOS platform in less than two weeks. The company is also expanding its partnership with Palantir Technologies, which will provide engineering resources and receive 4,644,922 shares of Surf Air Mobility stock. Additionally, Jason Secore has been appointed as CFO, effective September 30, succeeding Oliver Reeves, who will remain as an adviser. Surf Air Mobility shares were down 2.48% to $1.17 in premarket trading. https://openbell.ai/news/MAT:1790793978762 2026-09-30T18:46:18.762Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Mattel.jpg?width=250&height=187 Mattel Shares Decline after CEO Departure News Mattel, Inc. (NASDAQ: MAT) shares fell nearly 4% to $12.62 following the announcement that CEO Ynon Kreiz will resign on October 2 to join another company. Roger Lynch, currently a board member and CEO of Condé Nast, has been appointed as the new chairman and CEO, effective October 2. In its recent earnings report, Mattel posted a second-quarter adjusted EPS of $0.01, below the expected $0.04, while sales of $1.125 billion exceeded the consensus estimate of $1.101 billion. https://openbell.ai/news/PANW:1790793894266 2026-09-30T18:44:54.266Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Palo-Alto-Networks.jpg?width=250&height=187 Palo Alto Stock Rises on Cool Inflation, Easing Fed Fears Palo Alto Networks Inc (NASDAQ: PANW) shares rose 2.92% to $399.75, reaching a new 52-week high, driven by cooler-than-expected inflation data that alleviated concerns over potential Federal Reserve rate hikes. The Bureau of Economic Analysis reported a 0.3% increase in the Fed's preferred inflation gauge from July to August, below the anticipated 0.4%. Additionally, a new AI safety framework introduced by President Trump has eased investor fears regarding the disruption of legacy software businesses by emerging AI technologies. https://openbell.ai/news/MPC:1790793525193 2026-09-30T18:38:45.193Z daily 0.9 https://cdn.brandfetch.io/MPC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of oil and gas refining and marketing companies are trading higher. Catalysts include EIA data showing a combined diesel and gasoline inventory drawdown of almost 4 million barrels, almost quadrupling the consensus estimate, and possible investor optimism that the Trump administration will avoid an outright ban on diesel exports amid corporate pushback. openbell Financial News https://openbell.ai/news/CI:1790793428227 2026-09-30T18:37:08.227Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Cigna-Group.jpg?width=250&height=187 Cigna Sets Long-Term Goals, Unveils 2030 Modernization Strategy Cigna Group has introduced its 'Lead to One' strategic growth framework, aiming to enhance healthcare affordability and customer personalization. The company reaffirmed its 2026 financial outlook, targeting approximately $280 billion in consolidated adjusted revenues and at least $30.45 in adjusted earnings per share. Additionally, Cigna plans to implement a $3 billion modernization initiative and has set long-term financial targets, including a 10% to 14% adjusted EPS compound annual growth rate from 2026 to 2030. At the time of publication, Cigna's shares were down 0.44% to $274.04. https://openbell.ai/news/SNPS:1790793117153 2026-09-30T18:31:57.153Z daily 0.9 https://cdn.brandfetch.io/SNPS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Synopsys And OpenAI Announce Multi-Year Deal To Build GPT-Synopsys Chip Design Model, With Revenue Sharing And Software Licensing; Terms Not Disclosed openbell Financial News https://openbell.ai/news/CALM:1790793047177 2026-09-30T18:30:47.177Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Cracked-Egg-Among-Whole-Eggs-In-A-Carton.jpg?width=250&height=187 Cal-Maine Foods Stock Cracks Under Egg-Industry Pressure Cal-Maine Foods Inc. reported a loss of $1.26 per share for the first quarter, significantly missing the Wall Street estimate of a loss of 64 cents, while net sales fell 41.5% year over year to $539.6 million, below the expected $574.8 million. The company attributed its weak performance to low conventional wholesale egg prices, high input costs, and an ongoing supply imbalance. Cal-Maine anticipates that its prepared foods capacity will grow over 60% by the first half of fiscal 2028, which is expected to support future earnings, although it will not pay a cash dividend until it recovers a cumulative loss of $94.5 million. https://openbell.ai/news/HUN:1790793043117 2026-09-30T18:30:43.117Z daily 0.9 https://cdn.brandfetch.io/HUN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Maintains Neutral on Huntsman, Lowers Price Target to $9 Citigroup analyst Patrick Cunningham has maintained a Neutral rating on Huntsman (NYSE: HUN) and has lowered the price target from $11 to $9. This adjustment reflects the analyst's updated outlook on the company's performance. https://openbell.ai/news/MRK:1790792953668 2026-09-30T18:29:13.668Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/South-San-Francisco--Ca--Usa---May-1--20.jpg?width=250&height=187 Merck Says Investigational Skin Therapy Shows Potential Merck & Co Inc. presented positive initial results from its Phase 2b trial of the investigational monoclonal antibody tulisokibart for treating moderate to severe hidradenitis suppurativa at the EADV 2026 Congress. The trial met its primary endpoint, with 72% of high-dose patients achieving a Hidradenitis Suppurativa Clinical Response 50, significantly outperforming the placebo group. Secondary endpoints also showed improvements in response rates and quality of life metrics. Following the announcement, Merck's stock price decreased by 1.63% to $146.85. https://openbell.ai/news/CNTB:1790792849524 2026-09-30T18:27:29.524Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Boy-Using-Nasal-Spray-Bottle---Allergy-C.jpg?width=250&height=187 Connect Biopharma Reports Significant Drop In Treatment Failure With New COPD Therapy Connect Biopharma Holdings Limited (NASDAQ: CNTB) reported positive topline results from its global Phase 2 study of rademikibart, an anti-IL-4Rα antibody for COPD treatment. The therapy reduced treatment failure rates by 81% and new moderate to severe exacerbations by 85%, achieving a 100% reduction in hospital admissions and emergency visits. The company's shares rose 25% to $1.24 following the announcement. https://openbell.ai/news/USO:1790792619014 2026-09-30T18:23:39.014Z daily 0.9 https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud The Hormuz Letter Posts On X: 'Iran appears to have struck ADNOC's Bu Hasa facility southwest of Abu Dhabi, one of the UAE's largest onshore oil and gas fields' The Hormuz Letter reports that Iran has allegedly targeted ADNOC's Bu Hasa facility, a significant onshore oil and gas field located southwest of Abu Dhabi in the UAE. This incident may have implications for oil supply and market stability in the region, potentially affecting stock prices, including that of USO. https://openbell.ai/news/AMZN:1790792461343 2026-09-30T18:21:01.343Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Last-Chance-for-Amazon-Prime-Subscribers.jpg?width=250&height=187 AI Could Threaten Amazon’s Advertising Flywheel Before E-Commerce Amazon.com Inc. (NASDAQ: AMZN) generated $69 billion in advertising revenue in 2025, a 22% increase from the previous year, highlighting the importance of advertising in its retail marketplace. A recent analysis by Andreessen Horowitz suggests that AI assistants could disrupt Amazon's control over the shopping journey by influencing consumer purchasing decisions, potentially bypassing Amazon's sponsored listings. In response, Amazon is enhancing its AI capabilities with Alexa for Shopping, which has seen a significant increase in active users and interactions, while also integrating advertising into its AI experiences to maintain its advertising revenue stream. https://openbell.ai/news/FDS:1790792363628 2026-09-30T18:19:23.628Z daily 0.9 https://cdn.brandfetch.io/FDS/w/400/h/400?c=1idopYfmtR7ZKg8QMud FactSet Calls 2026 Margins the ‘Floor’ As It Targets Profitability Improvement FactSet Research Systems Inc. reported a 6.3% year-over-year revenue increase to $634.7 million for fiscal 2026, surpassing the $629.8 million estimate, with adjusted earnings of $4.52 per share beating expectations. The company anticipates fiscal 2027 revenue between $2.60 billion and $2.625 billion, reflecting a growth of 5% to 6%. FactSet's operating margins are expected to improve, with a projected expansion of 25 to 75 basis points, driven by productivity initiatives and AI efficiencies. Additionally, the company returned nearly $808 million to shareholders in fiscal 2026 through share repurchases and dividends. https://openbell.ai/news/FDS:1790792351532 2026-09-30T18:19:11.532Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Konskie--Poland---January-31--2024-Facts.jpg?width=250&height=187 FactSet Calls 2026 Margins the ‘Floor’ As It Targets Profitability Improvement FactSet Research Systems Inc. reported a 6.3% year-over-year revenue increase to $634.7 million for fiscal 2026, surpassing the $629.8 million consensus estimate. The company expects fiscal 2027 revenue between $2.60 billion and $2.625 billion, reflecting a growth of 5% to 6%. FactSet's adjusted earnings were $4.52 per share, exceeding the $4.33 estimate, and it returned nearly $808 million to shareholders in fiscal 2026. The company anticipates improved profitability with operating margin expansion of 25 to 75 basis points in fiscal 2027, supported by productivity measures and AI-driven efficiencies. https://openbell.ai/news/PAYS:1790792246897 2026-09-30T18:17:26.897Z daily 0.9 https://cdn.brandfetch.io/PAYS/w/400/h/400?c=1idopYfmtR7ZKg8QMud DA Davidson Maintains Buy on PaySign, Raises Price Target to $15 DA Davidson analyst Peter Heckmann has maintained a 'Buy' rating on PaySign (NASDAQ: PAYS) and increased the price target from $12 to $15. https://openbell.ai/news/FDS:1790792245223 2026-09-30T18:17:25.223Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Konskie--Poland---January-31--2024-Facts.jpg?width=250&height=187 FactSet Calls 2026 Margins the ‘Floor’ As It Targets a Profitability Rebound FactSet Research Systems Inc. reported a 6.3% year-over-year revenue increase to $634.7 million for fiscal 2026, surpassing the consensus estimate of $629.8 million. The company also achieved adjusted earnings of $4.52 per share, exceeding the $4.33 estimate. Despite strong fourth-quarter results, FactSet's fiscal 2027 guidance fell short of analyst expectations, projecting revenue growth of 5% to 6% and organic ASV growth of 5% to 6.5%. The company returned nearly $808 million to shareholders in fiscal 2026, including $644 million in share repurchases. https://openbell.ai/news/ADBE:1790792219089 2026-09-30T18:16:59.089Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Adobe.jpg?width=250&height=187 Why Is Adobe Stock Surging on Wednesday? Adobe (NASDAQ: ADBE) stock surged 2.278% to $239.66 on Wednesday, driven by a broader rally in technology stocks following lower-than-expected inflation data. The personal consumption expenditures (PCE) price index rose 0.3% month over month, below the anticipated 0.4%. Despite this uptick, Adobe's stock is down 32.04% year to date and trades at a forward price-to-earnings ratio of 8.45, indicating a significant valuation discount compared to its peers. Additionally, Adobe reported a 150% year-over-year growth in its artificial intelligence annual recurring revenue and forecasts a 6.7% increase in U.S. online holiday spending this season. https://openbell.ai/news/BTCUSD:1790792130025 2026-09-30T18:15:30.025Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Bitcoin-Whale---Whale-In-Ocean-And-Bitco.jpg?width=250&height=187 Bitcoin Whales Add 41,000 BTC in 10 Days as Retail Passes: What’s Happening? Bitcoin whales have accumulated 41,025 BTC over the past 10 days, bringing their total holdings to 13.64 million BTC, which is 67.93% of Bitcoin's total supply. This accumulation occurs while retail investors, particularly those holding less than 0.01 BTC, have remained inactive. Analyst Kevin Capital estimates a 90% probability that Bitcoin's cycle low is already in, with key price zones identified between $77,000 to $83,000 for potential upward movement towards $100,000. https://openbell.ai/news/AEON:1790792017519 2026-09-30T18:13:37.519Z daily 0.9 https://cdn.brandfetch.io/AEON/w/400/h/400?c=1idopYfmtR7ZKg8QMud AEON Biopharma shares are trading higher after the company announced that the FDA indicated previously completed ABP-450 head-to-head studies versus BOTOX may be submitted as supportive evidence. openbell Financial News https://openbell.ai/news/LGHL:1790791965555 2026-09-30T18:12:45.555Z daily 0.9 https://cdn.brandfetch.io/LGHL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Lion Group Says It Sold All Its Solana And Some Bitcoin To Buy 38,102 Hyperliquid Tokens, Lifting HYPE Holdings To 232,900 Worth About $20.1M openbell Financial News https://openbell.ai/news/SGMT:1790791915488 2026-09-30T18:11:55.488Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Woman-Hand-Holding-Healthcare-Medical-Ic.jpg?width=250&height=187 Sagimet Biosciences Surges Forward With Successful Acne Clinical Data and Capital Raise Sagimet Biosciences Inc. (NASDAQ: SGMT) reported positive 52-week data from a Phase 3 trial of denifanstat for moderate to severe acne, achieving a treatment success rate of 56.7% and significant reductions in inflammatory lesions. The company has priced an underwritten public offering of 8.75 million shares at $10.00 each, aiming to raise approximately $115 million in gross proceeds. Sagimet plans to use the funds for further development of denifanstat and other corporate purposes. Following the announcement, Sagimet's stock rose by 8.57% to $10.13. https://openbell.ai/news/ONMD:1790791817455 2026-09-30T18:10:17.455Z daily 0.9 https://cdn.brandfetch.io/ONMD/w/400/h/400?c=1idopYfmtR7ZKg8QMud OneMedNet shares are trading higher after the company announced a seven-figure multi-year agreement to deliver de-identified, multimodal, longitudinal clinical Real World Data to a commercially scaled AI-enabled precision medicine company. openbell Financial News https://openbell.ai/news/USO:1790791768881 2026-09-30T18:09:28.881Z daily 0.9 https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported September 29, 'White House holds crunch talks on diesel export ban as midterms near' - Financial Times openbell Financial News https://openbell.ai/news/VBIO:1790791721910 2026-09-30T18:08:41.910Z daily 0.9 https://cdn.brandfetch.io/VBIO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Valion Bio shares are trading higher after the company announced the completion of formulation work under the company's ongoing program to develop a novel oral mucosal formulation of Entolimod with Shear Kershman Laboratories. openbell Financial News https://openbell.ai/news/HCTI:1790791685666 2026-09-30T18:08:05.666Z daily 0.9 https://cdn.brandfetch.io/HCTI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Healthcare Triangle Signs MOU For 70%-Owned Joint Venture With AI World To Deploy Humanoid Nursing Robots In North American Hospitals openbell Financial News https://openbell.ai/news/SNPS:1790791319673 2026-09-30T18:01:59.673Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Konskie--Poland---November-15--2024-Syno.jpg?width=250&height=187 Amazon Signs Up As Synopsys' Lead Customer In $1 Billion-Plus Chip Pact Synopsys Inc (NASDAQ: SNPS) has entered into a multi-year strategic agreement with Amazon.com, Inc. (NASDAQ: AMZN) valued at over $1 billion to enhance the development of custom silicon for AI applications. This partnership will utilize AWS services to accelerate product development and optimize Synopsys' software for Amazon’s Trainium and Graviton chips. Following the announcement, Synopsys shares rose by nearly 2%, trading at $422.29. https://openbell.ai/news/VALE:1790791167724 2026-09-30T17:59:27.724Z daily 0.9 https://cdn.brandfetch.io/VALE/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Maintains Overweight on Vale, Raises Price Target to $22 JP Morgan analyst Rodolfo Angele has maintained an Overweight rating on Vale (NYSE: VALE) and increased the price target from $21 to $22. This adjustment reflects the firm's positive outlook on the company's performance. https://openbell.ai/news/TLSA:1790791152055 2026-09-30T17:59:12.055Z daily 0.9 https://cdn.brandfetch.io/TLSA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Tiziana Life Sciences shares are trading higher after the company announced that it has submitted a request to the FDA for Orphan Drug Designation for intranasal foralumab for the treatment of Multiple System Atrophy. openbell Financial News https://openbell.ai/news/HRL:1790791112150 2026-09-30T17:58:32.150Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Hormel-Foods.jpg?width=250&height=187 Hormel Strikes $1.06 Billion Deal to Expand Its Chicken Business Hormel Foods Corp. has agreed to acquire Brakebush Brothers LLC for approximately $1.055 billion, aiming to enhance its presence in the value-added chicken market. Brakebush generated about $1.2 billion in net sales over the past year and operates multiple production facilities. The transaction is expected to close in Hormel's fiscal first quarter of 2027 and is projected to contribute to adjusted earnings per share starting in fiscal 2028. Hormel's shares rose 0.98% to $20.04 following the announcement. https://openbell.ai/news/UZX:1790791078186 2026-09-30T17:57:58.186Z daily 0.9 https://cdn.brandfetch.io/UZX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Linkage Global shares are trading lower after the company announced the termination of the non-binding letter of intent with Capital Finance. openbell Financial News https://openbell.ai/news/HUT:1790791053647 2026-09-30T17:57:33.647Z daily 0.9 https://cdn.brandfetch.io/HUT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Hut 8 shares are trading lower. A Form 144 filing indicated that a director who holds 1.5 million shares under an expiring lockup, received as payment for the acquisition of US Bitcoin Corp in 2023, plans to sell the shares. openbell Financial News https://openbell.ai/news/LLY:1790790598611 2026-09-30T17:49:58.611Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Prague--Czechia---30--May-2025-Eli-Lilly.jpg?width=250&height=187 Eli Lilly Data Shows Retatrutide Promotes Weight Loss Over Eighty Weeks Eli Lilly and Co. reported positive results from late-stage trials for retatrutide, a triple hormone receptor agonist, showing an average weight loss of 49.6 pounds (20.8% reduction) over 80 weeks. Patients with a BMI of 35 or greater lost an average of 60.8 pounds, and nearly 60% no longer met obesity criteria. The treatment also improved blood sugar levels, reducing A1C by up to 1.6%, with plans to file a Biologics License Application with the FDA in Q1 2027. Eli Lilly shares rose 0.24% to $1187.47 following the announcement. https://openbell.ai/news/SNOW:1790790571093 2026-09-30T17:49:31.093Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Snowflake-Inc.jpg?width=250&height=187 What's Going On With Snowflake Stock Wednesday? Snowflake Inc. (NYSE: SNOW) stock rose approximately 4% on Wednesday, trading at $343.59, as investors showed interest in cloud and AI-related software stocks. The company announced an expanded five-year partnership with LSEG, which will integrate LSEG’s financial data with Snowflake’s AI Data Cloud, enhancing joint market efforts and customer access to data. Analysts maintain a Buy consensus rating for Snowflake, with price forecasts ranging from $350 to $450. https://openbell.ai/news/TXG:1790790536674 2026-09-30T17:48:56.674Z daily 0.9 https://cdn.brandfetch.io/TXG/w/400/h/400?c=1idopYfmtR7ZKg8QMud 10x Genomics shares are trading higher after the company launched its Sentira cloud-based spatial analysis tool and announced the first shipments of its Atera transcriptome analysis tool. openbell Financial News https://openbell.ai/news/CRM:1790790468143 2026-09-30T17:47:48.143Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Salesforce.jpg?width=250&height=187 Why Is Salesforce Stock Surging on Wednesday? Salesforce Inc (NYSE: CRM) stock surged 1.85% to $229.47 on Wednesday, driven by a broader recovery in tech stocks following cooler inflation data from the Bureau of Economic Analysis, which reported a 0.3% month-over-month increase in the PCE price index for August, below the expected 0.4%. Additionally, Salesforce announced a definitive agreement to acquire AI customer research platform Listen Labs. The Nasdaq and S&P 500 also saw gains of 0.81% and 0.60%, respectively, as technology stocks led the sectors with a 1.18% increase. https://openbell.ai/news/ANNX:1790790413892 2026-09-30T17:46:53.892Z daily 0.9 https://cdn.brandfetch.io/ANNX/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Maintains Overweight on Annexon, Raises Price Target to $15 JP Morgan analyst Anupam Rama has maintained an Overweight rating on Annexon (NASDAQ: ANNX) and increased the price target from $14 to $15. This adjustment reflects a positive outlook for the company in the market. https://openbell.ai/news/ZECUSD:1790790380057 2026-09-30T17:46:20.057Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Coin-Cryptocurrency-Zcash-On-The-Backgro.jpg?width=250&height=187 Bitcoin, XRP Have Utility but One Privacy Token Is Gaining Market Share Zcash (CRYPTO: ZEC) has experienced a significant price increase from approximately $60 to $1,500 over the past year, with its market capitalization rising from less than 0.1% to nearly 1.5% of Bitcoin's market cap. Grayscale's Head of Research, Zach Pandl, suggests that Zcash's growth is justified by its low initial valuation and a potentially large addressable market. Investment experts, including Bitwise's Matt Hougan, view privacy-focused cryptocurrencies like Zcash as emerging long-term themes that could challenge established leaders in the crypto sector. https://openbell.ai/news/NOC:1790790185645 2026-09-30T17:43:05.645Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Saint-Petersburg--Russia---29-March-2020.jpg?width=250&height=187 Why Is Northrop Grumman Stock Falling on Wednesday? Northrop Grumman Corp. (NYSE: NOC) shares fell 3.87% to $485.10 after the U.S. Navy awarded a contract worth over $20 billion to Boeing Co. for the development of the next-generation F/A-XX carrier-based fighter jet, sidelining Northrop. The F/A-XX program could potentially be worth hundreds of billions as production increases and foreign orders arise. Northrop's stock is trading near its 52-week low of $479.02. https://openbell.ai/news/ZBAO:1790790146091 2026-09-30T17:42:26.091Z daily 0.9 https://cdn.brandfetch.io/ZBAO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Zhibao Technology shares are trading higher after the company announced it expects full-year revenue growth of 10% to 20% for the fiscal year ended June 30, 2026. openbell Financial News https://openbell.ai/news/PPTA:1790790127009 2026-09-30T17:42:07.009Z daily 0.9 https://cdn.brandfetch.io/PPTA/w/400/h/400?c=1idopYfmtR7ZKg8QMud HC Wainwright & Co. Reiterates Buy on Perpetua Resources, Maintains $43.5 Price Target HC Wainwright & Co. analyst Heiko F. Ihle has reiterated a 'Buy' rating on Perpetua Resources (NASDAQ: PPTA) and maintained a price target of $43.5. This endorsement reflects confidence in the company's performance and potential for growth. https://openbell.ai/news/RFL:1790789950254 2026-09-30T17:39:10.254Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Modern-Biotechnology-Scientific-Research.jpg?width=250&height=187 Why Is Rafael Stock Falling Wednesday? Rafael Holdings Inc. (NYSE: RFL) stock fell 37.89% to $1.26 after the company reported topline results from its Phase 3 TransportNPC study of Trappsol Cyclo for Niemann-Pick Disease Type C. Although the drug showed a 64% reduction in disease progression at Week 96, it did not meet the primary endpoint's statistical significance. However, a subgroup analysis indicated a 71% reduction in disease progression, which may support a New Drug Application submission in Q4 2026. The company's market capitalization was approximately $105.6 million, contributing to the stock's volatility. https://openbell.ai/news/LNAI:1790789947283 2026-09-30T17:39:07.283Z daily 0.9 https://cdn.brandfetch.io/LNAI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Lunai Bioworks shares are trading lower after the company announced it filed for a non-timely 10-K with the U.S. SEC and anticipates reporting a net loss for the fiscal year ended June 30, 2026, of approximately $3.2 million. openbell Financial News